RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION

Abstract

Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-group differences. Ramipril is the one of the most studied drug of this group recommended for patients after acute myocardial infarction.

Keywords

• острый инфаркт миокарда
• ангиотензинпревращающий фермент
• рамиприл